RECRUITING

Personalized Real-Time DBS and PD Mechanisms

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A prospective cohort of patients scheduled to undergo deep brain stimulation (DBS) implantation surgery for the treatment of Parkinson's disease as per standard of care will be invited to participate in this study. This mechanistic study is aimed at better understanding the role of basal ganglia beta band (11-35 Hz) oscillations and resonance in the manifestation of Parkinson's disease (PD) motor signs using closed-loop electrical neurostimulation, levodopa medication, and computational modeling. The ultimate goal of this study is to inform the development of closed-loop neuromodulation technology that can be programmed and adjusted in real time based on patient-specific neural activity.

Official Title

Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinson's Disease Using Real-Time Neural Control

Quick Facts

Study Start:2023-08-29
Study Completion:2028-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06013956

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability to provide informed consent.
  2. * Clinical diagnosis of idiopathic Parkinson's disease.
  3. * Determined, as per standard of care, to be a candidate for deep brain stimulation (DBS) surgery targeting either the subthalamic nucleus or the internal segment of the globus pallidus.
  4. * Ability to tolerate delays in taking daily standard Parkinson's disease medications.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

David Escobar, PhD
CONTACT
216-390-1907
escobad2@ccf.org
Jeffrey Negrey, MA
CONTACT
216-316-6896
negreyj2@ccf.org

Study Locations (Sites)

Cleveland Clinic
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: David Escobar

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-29
Study Completion Date2028-06-30

Study Record Updates

Study Start Date2023-08-29
Study Completion Date2028-06-30

Terms related to this study

Keywords Provided by Researchers

  • Deep Brain Stimulation

Additional Relevant MeSH Terms

  • Parkinson Disease